Browse Category

Market News News 9 January 2026 - 11 January 2026

Kratos Defense stock (KTOS) jumps again on Valkyrie drone deal, Trump budget push and fresh target hikes

Kratos Defense stock (KTOS) jumps again on Valkyrie drone deal, Trump budget push and fresh target hikes

New York, Jan 10, 2026, 21:10 EST — Market closed. Shares of Kratos Defense & Security Solutions (KTOS) ended Friday at $113.70, gaining 9.3% after fluctuating between $104.65 and $115.45. The stock has surged roughly 43% since closing on Jan. 2, with about 6 million shares changing hands Friday. (Nasdaq) The recent surge came after a defense-sector rally sparked by…
SoundHound AI stock jumps into the weekend after D.A. Davidson trims target; traders eye Monday

SoundHound AI stock jumps into the weekend after D.A. Davidson trims target; traders eye Monday

NEW YORK, January 10, 2026, 19:53 EST — The market has closed. SoundHound AI’s shares jumped 6.7% Friday, closing at $11.75 after hitting a session peak of $12.31. Volume swelled to roughly 39.3 million shares, unusually high for the company’s scale. That bounce is crucial since SOUN now serves as a fast indicator of risk appetite in smaller AI stocks.…
Archer Aviation stock (ACHR) set for Monday test after Nvidia IGX Thor air-taxi AI plan

Archer Aviation stock (ACHR) set for Monday test after Nvidia IGX Thor air-taxi AI plan

New York, Jan 10, 2026, 19:24 ET — The market has closed. Archer Aviation shares ended Friday’s session 1.2% higher, closing at $8.81. With U.S. markets closed for the weekend, investors will have to wait until Monday for the next price update. Archer, the air-taxi maker, saw a boost at CES after revealing its collaboration with Nvidia on onboard computing…
Linde (LIN) stock rises as company sets Feb. 5 earnings date — what investors watch next

Linde (LIN) stock rises as company sets Feb. 5 earnings date — what investors watch next

New York, Jan 10, 2026, 16:55 (EST) — The market has closed. Linde plc shares ended the last session 1% higher at $444.08, marking a key moment as the industrial gases company approaches earnings season. U.S. stocks have hit record highs, and with every new data point nudging rate expectations, even minor shifts can impact steady earners like Linde. Now,…
ASML stock jumps on HSBC target lift, TSMC revenue beat; next test is Jan 28 earnings

ASML stock jumps on HSBC target lift, TSMC revenue beat; next test is Jan 28 earnings

AMSTERDAM, Jan 10, 2026, 11:04 CET — Market closed ASML Holding N.V. shares surged Friday, propelled by HSBC’s raised price target. The Dutch chip equipment giant led gains in Europe’s tech sector. Meanwhile, strong revenue from major client Taiwan Semiconductor Manufacturing Co helped boost confidence across chip stocks. (Reuters) The move follows investor attempts to gauge if the recent spike…
Oklo stock jumps on Meta nuclear campus deal — what investors watch before Monday

Oklo stock jumps on Meta nuclear campus deal — what investors watch before Monday

New York, January 10, 2026, 04:59 EST — Market closed Oklo Inc shares jumped 7.9% on Friday, wrapping up at $105.31. The surge came after Meta Platforms threw its support behind a 1.2-gigawatt nuclear power campus in Ohio, linked to its expanding data-center operations. Big Tech is rushing to lock in reliable power as data centers and AI drive up…
Rolls-Royce stock at fresh 52-week high: buyback, Istanbul engine hub and UK SMR plans in focus

Rolls-Royce stock at fresh 52-week high: buyback, Istanbul engine hub and UK SMR plans in focus

London, Jan 10, 2026, 07:54 GMT — Market closed Rolls-Royce Holdings plc shares closed at a new 52-week high on Friday, extending a week of record closes as investors sized up fresh civil-aerospace and nuclear headlines and the company’s ongoing share repurchases. The stock ended up 1.65% at 1,293.5 pence, with turnover below its recent average. (MarketWatch) The move matters…
10 January 2026
Westpac shares (ASX:WBC) in focus after bushfire relief package as rate outlook shifts

Westpac shares (ASX:WBC) in focus after bushfire relief package as rate outlook shifts

Sydney, Jan 10, 2026, 17:14 AEDT — Market closed Westpac Banking Corp said on Saturday it would roll out a disaster relief package for customers affected by Victorian bushfires, days after its shares slipped with the broader bank sector. (Mirage News) The move lands as fires burn across parts of Victoria and force evacuations, lifting scrutiny on household cash flow,…
IREN stock steadies after-hours after Bernstein reiterates “top AI pick” view

IREN stock steadies after-hours after Bernstein reiterates “top AI pick” view

New York, January 9, 2026, 17:55 EST — After-hours IREN Ltd shares edged higher in after-hours trading on Friday after a Bernstein analyst again flagged the company as a preferred way to play the overlap between bitcoin mining and AI data centers. The stock was up 0.7% at $46.03. The call matters because the trade in crypto-linked miners has been…
Strategy Inc stock slides after hours as bitcoin slips and a fresh MSTR target cut lands

Strategy Inc stock slides after hours as bitcoin slips and a fresh MSTR target cut lands

New York, Jan 9, 2026, 16:41 ET — After-hours Strategy Inc (MSTR.O) shares were down 5.8% at $157.33 in after-hours trade on Friday, after sliding as low as $155.51 earlier in the day. Bitcoin fell 0.9% to $90,356. The move matters because Strategy trades less like a software firm these days and more like a high-beta bet on bitcoin, with…
TG Therapeutics (TGTX) stock drops 7% as JPMorgan healthcare conference nears — what investors watch next

TG Therapeutics (TGTX) stock drops 7% as JPMorgan healthcare conference nears — what investors watch next

New York, January 9, 2026, 15:59 (EST) — Regular session TG Therapeutics (TGTX.O) shares fell about 7% on Friday, reversing an early rise and leaving the biotech near its session low. The stock was down 7% at $28.35 by 3:55 p.m. EST after opening at $30.69 and sliding as low as $28.215. It hit $30.83 earlier in the session. The…
1 7 8 9 10 11 64

Stock Market Today

  • Pfizer Q4 Preview: Non-Oncology Segment Sales Outlook and Market Impact
    January 19, 2026, 11:10 AM EST. Pfizer (PFE) is scheduled to report Q4 and full-year 2025 earnings on Feb. 3. While oncology sales account for over 28% of revenues, investor focus also shifts to non-oncology segments including Primary Care and Specialty Care. Key non-oncology products include Eliquis anticoagulant, Prevnar vaccines, COVID-19 vaccine Comirnaty, and newer drugs like RSV vaccine Abrysvo and migraine treatment Nurtec. Eliquis alliance revenues are expected to rise to $2.1 billion despite generic pressures. Prevnar vaccine sales likely declined in the U.S. but increased internationally, estimated at $1.64 billion. COVID-19 medication sales fell due to narrower vaccine recommendations and lower infections. In Specialty Care, Vyndaqel sales remain strong at an estimated $1.66 billion, while Xeljanz and Enbrel may have weakened. Pfizer's stock dropped 2.5% in past year, underperforming the industry, but trades at a forward price/earnings ratio of 8.58, suggesting valuation appeal.
Go toTop